A recently awarded grant will fund a human clinical trial in type 1 diabetes beginning in early 2015 to see if verapamil will have an effect in humans by attacking the disease where it occurs. Meanwhile, more small molecule drugs at UAB are in development.
A recently awarded grant will fund a human clinical trial in type 1 diabetes beginning in early 2015 to see if verapamil will have an effect in humans by attacking the disease where it occurs. Meanwhile, more small molecule drugs at UAB are in development.